Loading...

FITC anti-mouse CD4 Antibody FITC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_FITC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
  • GK1.5_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100405 50 µg SEK252
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100406 500 µg SEK832
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  2. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  3. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  4. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  5. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  6. Liu J, et al. 2021. Front Immunol. 12:747730. PubMed
  7. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  8. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  9. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  10. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  11. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  12. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  13. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  14. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  15. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  16. Balood M, et al. 2022. Nature. 611:405. PubMed
  17. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  18. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  19. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  20. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  21. Chen C, et al. 2022. J Neuroinflammation. 19:315. PubMed
  22. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  23. Merk VM, et al. 2023. Genes Immun. 24:52. PubMed
  24. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  25. Sun Y, et al. 2023. Cell Mol Life Sci. 80:63. PubMed
  26. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  27. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  28. Zander R, et al. 2022. Immunity. 55:475. PubMed
  29. Qiu Z, et al. 2022. J Exp Med. 219:. PubMed
  30. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  31. Hamdi L, et al. 2022. Ann Clin Transl Neurol. 9:1792. PubMed
  32. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  33. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  34. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  35. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  36. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  37. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  38. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  39. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  40. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  41. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  42. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  43. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  44. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  45. Peymanfar Y, et al. 2023. Int J Mol Sci. 24:. PubMed
  46. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  47. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
  48. Iwanami N, et al. 2023. Nat Commun. 14:3645. PubMed
  49. Solvay M, et al. 2023. J Immunother Cancer. 11:. PubMed
  50. Wang Z, et al. 2023. Sci Adv. 9:eabo4100. PubMed
  51. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  52. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  53. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  54. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  55. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  56. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  57. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  58. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  59. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  60. He R, et al. 2021. J Immunol. 206:2353. PubMed
  61. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  62. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  63. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  64. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  65. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  66. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  67. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  68. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  69. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  70. Toomer G, et al. 2022. Viruses. 14:. PubMed
  71. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  72. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  73. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  74. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  75. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  76. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  77. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  78. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  79. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  80. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  81. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  82. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  83. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  84. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  85. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  86. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  87. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  88. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  89. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  90. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  91. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  92. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  93. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  94. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  95. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  96. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  97. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  98. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  99. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  100. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  101. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  102. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  103. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  104. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  105. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  106. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  107. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  108. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  109. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  110. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  111. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  112. White C, et al. 2014. J Immunol. 193:5933. PubMed
  113. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  114. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  115. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  116. Feng H, et al. 2020. J Dermatol. 47:147. PubMed
  117. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  118. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  119. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  120. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  121. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  122. He X, et al. 2021. Small. 17:e2007165. PubMed
  123. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  124. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  125. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  126. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  127. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  128. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  129. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  130. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  131. Wang Z, et al. 2022. Nat Biomed Eng. 6:791. PubMed
  132. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  133. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  134. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  135. Deng Z, et al. 2020. World J Gastrointest Oncol. 1091:12. PubMed
  136. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  137. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  138. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  139. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  140. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  141. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  142. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  143. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  144. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  145. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  146. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  147. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  148. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  149. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  150. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  151. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  152. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  153. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  154. Gebre MS, et al. 2022. NPJ Vaccines. 7:88. PubMed
  155. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  156. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  157. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  158. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  159. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  160. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  161. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  162. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  163. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  164. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  165. Lang V, et al. 2021. Elife. 10:. PubMed
  166. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  167. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  168. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  169. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  170. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  171. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  172. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  173. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  174. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  175. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  176. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  177. Ma K, et al. 2022. iScience. 25:104347. PubMed
  178. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  179. Gao X, et al. 2022. Front Immunol. 13:799331. PubMed
  180. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  181. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  182. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  183. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  184. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  185. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  186. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  187. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  188. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  189. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  190. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  191. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  192. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  193. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  194. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  195. Li J, et al. 2020. Development. :. PubMed
  196. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  197. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  198. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  199. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  200. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  201. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  202. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  203. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  204. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  205. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  206. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  207. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  208. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  209. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  210. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  211. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  212. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  213. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  214. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  215. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  216. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  217. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  218. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  219. Pan L, et al. 2022. Front Immunol. 13:837497. PubMed
  220. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  221. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  222. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  223. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  224. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  225. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  226. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  227. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  228. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  229. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  230. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  231. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  232. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  233. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  234. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  235. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  236. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  237. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  238. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  239. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  240. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  241. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  242. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  243. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  244. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  245. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  246. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  247. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  248. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  249. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  250. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  251. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  252. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  253. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  254. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  255. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  256. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  257. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  258. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  259. Gawish R, et al. 2022. Elife. 11:. PubMed
  260. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  261. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  262. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  263. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  264. Zeng A, et al. 2020. Oncol Rep. . PubMed
  265. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  266. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  267. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  268. Lestari SR, et al. 2020. J Ayurveda Integr Med. 11:414. PubMed
  269. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  270. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  271. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  272. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  273. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  274. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  275. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  276. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  277. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  278. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  279. Liu J, et al. 2021. Front Immunol. 12:747730. PubMed
  280. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  281. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  282. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  283. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  284. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  285. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  286. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  287. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  288. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  289. Balood M, et al. 2022. Nature. 611:405. PubMed
  290. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  291. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  292. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  293. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  294. Chen C, et al. 2022. J Neuroinflammation. 19:315. PubMed
  295. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  296. Merk VM, et al. 2023. Genes Immun. 24:52. PubMed
  297. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  298. Sun Y, et al. 2023. Cell Mol Life Sci. 80:63. PubMed
  299. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  300. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  301. Zander R, et al. 2022. Immunity. 55:475. PubMed
  302. Qiu Z, et al. 2022. J Exp Med. 219:. PubMed
  303. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  304. Hamdi L, et al. 2022. Ann Clin Transl Neurol. 9:1792. PubMed
  305. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  306. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  307. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  308. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  309. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  310. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  311. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  312. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  313. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  314. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  315. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  316. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  317. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  318. Peymanfar Y, et al. 2023. Int J Mol Sci. 24:. PubMed
  319. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  320. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
  321. Iwanami N, et al. 2023. Nat Commun. 14:3645. PubMed
  322. Solvay M, et al. 2023. J Immunother Cancer. 11:. PubMed
  323. Wang Z, et al. 2023. Sci Adv. 9:eabo4100. PubMed
  324. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  325. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  326. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  327. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  328. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  329. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  330. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  331. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  332. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  333. He R, et al. 2021. J Immunol. 206:2353. PubMed
  334. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  335. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  337. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  338. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  339. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  340. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  341. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  342. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  343. Toomer G, et al. 2022. Viruses. 14:. PubMed
  344. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  345. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  346. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  347. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  348. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  349. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  350. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  351. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  352. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  353. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  354. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  355. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  356. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  357. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  358. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  359. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  360. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  361. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  362. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  363. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  364. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  365. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  366. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  367. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  368. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  369. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  370. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  371. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  372. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  373. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  374. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  375. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  376. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  377. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  378. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  379. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  380. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  381. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  382. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  383. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  384. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  385. White C, et al. 2014. J Immunol. 193:5933. PubMed
  386. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  387. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  388. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  389. Feng H, et al. 2020. J Dermatol. 47:147. PubMed
  390. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  391. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  392. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  393. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  394. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  395. He X, et al. 2021. Small. 17:e2007165. PubMed
  396. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  397. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  398. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  399. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  400. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  401. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  402. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  403. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  404. Wang Z, et al. 2022. Nat Biomed Eng. 6:791. PubMed
  405. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  406. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  407. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  408. Deng Z, et al. 2020. World J Gastrointest Oncol. 1091:12. PubMed
  409. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  410. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  411. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  412. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  413. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  414. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  415. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  416. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  417. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  418. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  419. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  420. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  421. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  422. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  423. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  424. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  425. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  426. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  427. Gebre MS, et al. 2022. NPJ Vaccines. 7:88. PubMed
  428. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  429. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  430. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  431. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  432. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  433. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  434. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  435. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  436. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  437. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  438. Lang V, et al. 2021. Elife. 10:. PubMed
  439. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  440. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  441. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  442. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  443. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  444. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  445. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  446. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  447. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  448. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  449. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  450. Ma K, et al. 2022. iScience. 25:104347. PubMed
  451. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  452. Gao X, et al. 2022. Front Immunol. 13:799331. PubMed
  453. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  454. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  455. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  456. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  457. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  458. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  459. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  460. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  461. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  462. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  463. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  464. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  465. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  466. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  467. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  468. Li J, et al. 2020. Development. :. PubMed
  469. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  470. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  471. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  472. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  473. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  474. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  475. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  476. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  477. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  478. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  479. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  480. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  481. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  482. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  483. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  484. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  485. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  486. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  487. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  488. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  489. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  490. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  491. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  492. Pan L, et al. 2022. Front Immunol. 13:837497. PubMed
  493. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  494. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  495. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  496. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  497. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  498. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  499. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  500. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  501. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  502. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  503. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  504. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  505. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  506. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  507. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  508. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  509. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  510. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  511. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  512. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  513. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  514. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  515. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  516. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  517. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  518. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  519. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  520. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  521. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  522. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  523. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  524. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  525. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  526. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  527. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  528. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  529. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  530. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  531. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  532. Gawish R, et al. 2022. Elife. 11:. PubMed
  533. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  534. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  535. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  536. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  537. Zeng A, et al. 2020. Oncol Rep. . PubMed
  538. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  539. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  540. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  541. Lestari SR, et al. 2020. J Ayurveda Integr Med. 11:414. PubMed
  542. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  543. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  544. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  545. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  546. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
RRID
AB_312690 (BioLegend Cat. No. 100405)
AB_312691 (BioLegend Cat. No. 100406)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_FITC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
  • GK1.5_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100405 50 µg SEK252
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100406 500 µg SEK832
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  2. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  3. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  4. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  5. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  6. Liu J, et al. 2021. Front Immunol. 12:747730. PubMed
  7. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  8. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  9. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  10. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  11. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  12. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  13. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  14. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  15. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  16. Balood M, et al. 2022. Nature. 611:405. PubMed
  17. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  18. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  19. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  20. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  21. Chen C, et al. 2022. J Neuroinflammation. 19:315. PubMed
  22. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  23. Merk VM, et al. 2023. Genes Immun. 24:52. PubMed
  24. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  25. Sun Y, et al. 2023. Cell Mol Life Sci. 80:63. PubMed
  26. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  27. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  28. Zander R, et al. 2022. Immunity. 55:475. PubMed
  29. Qiu Z, et al. 2022. J Exp Med. 219:. PubMed
  30. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  31. Hamdi L, et al. 2022. Ann Clin Transl Neurol. 9:1792. PubMed
  32. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  33. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  34. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  35. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  36. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  37. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  38. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  39. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  40. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  41. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  42. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  43. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  44. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  45. Peymanfar Y, et al. 2023. Int J Mol Sci. 24:. PubMed
  46. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  47. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
  48. Iwanami N, et al. 2023. Nat Commun. 14:3645. PubMed
  49. Solvay M, et al. 2023. J Immunother Cancer. 11:. PubMed
  50. Wang Z, et al. 2023. Sci Adv. 9:eabo4100. PubMed
  51. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  52. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  53. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  54. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  55. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  56. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  57. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  58. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  59. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  60. He R, et al. 2021. J Immunol. 206:2353. PubMed
  61. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  62. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  63. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  64. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  65. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  66. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  67. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  68. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  69. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  70. Toomer G, et al. 2022. Viruses. 14:. PubMed
  71. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  72. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  73. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  74. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  75. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  76. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  77. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  78. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  79. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  80. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  81. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  82. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  83. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  84. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  85. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  86. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  87. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  88. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  89. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  90. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  91. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  92. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  93. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  94. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  95. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  96. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  97. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  98. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  99. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  100. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  101. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  102. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  103. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  104. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  105. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  106. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  107. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  108. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  109. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  110. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  111. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  112. White C, et al. 2014. J Immunol. 193:5933. PubMed
  113. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  114. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  115. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  116. Feng H, et al. 2020. J Dermatol. 47:147. PubMed
  117. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  118. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  119. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  120. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  121. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  122. He X, et al. 2021. Small. 17:e2007165. PubMed
  123. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  124. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  125. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  126. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  127. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  128. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  129. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  130. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  131. Wang Z, et al. 2022. Nat Biomed Eng. 6:791. PubMed
  132. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  133. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  134. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  135. Deng Z, et al. 2020. World J Gastrointest Oncol. 1091:12. PubMed
  136. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  137. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  138. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  139. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  140. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  141. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  142. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  143. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  144. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  145. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  146. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  147. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  148. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  149. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  150. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  151. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  152. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  153. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  154. Gebre MS, et al. 2022. NPJ Vaccines. 7:88. PubMed
  155. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  156. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  157. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  158. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  159. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  160. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  161. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  162. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  163. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  164. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  165. Lang V, et al. 2021. Elife. 10:. PubMed
  166. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  167. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  168. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  169. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  170. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  171. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  172. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  173. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  174. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  175. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  176. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  177. Ma K, et al. 2022. iScience. 25:104347. PubMed
  178. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  179. Gao X, et al. 2022. Front Immunol. 13:799331. PubMed
  180. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  181. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  182. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  183. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  184. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  185. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  186. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  187. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  188. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  189. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  190. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  191. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  192. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  193. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  194. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  195. Li J, et al. 2020. Development. :. PubMed
  196. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  197. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  198. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  199. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  200. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  201. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  202. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  203. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  204. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  205. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  206. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  207. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  208. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  209. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  210. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  211. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  212. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  213. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  214. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  215. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  216. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  217. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  218. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  219. Pan L, et al. 2022. Front Immunol. 13:837497. PubMed
  220. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  221. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  222. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  223. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  224. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  225. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  226. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  227. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  228. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  229. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  230. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  231. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  232. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  233. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  234. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  235. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  236. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  237. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  238. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  239. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  240. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  241. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  242. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  243. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  244. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  245. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  246. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  247. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  248. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  249. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  250. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  251. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  252. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  253. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  254. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  255. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  256. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  257. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  258. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  259. Gawish R, et al. 2022. Elife. 11:. PubMed
  260. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  261. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  262. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  263. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  264. Zeng A, et al. 2020. Oncol Rep. . PubMed
  265. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  266. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  267. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  268. Lestari SR, et al. 2020. J Ayurveda Integr Med. 11:414. PubMed
  269. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  270. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  271. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  272. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  273. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  274. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  275. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  276. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  277. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  278. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  279. Liu J, et al. 2021. Front Immunol. 12:747730. PubMed
  280. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  281. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  282. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  283. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  284. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  285. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  286. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  287. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  288. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  289. Balood M, et al. 2022. Nature. 611:405. PubMed
  290. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  291. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  292. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  293. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  294. Chen C, et al. 2022. J Neuroinflammation. 19:315. PubMed
  295. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  296. Merk VM, et al. 2023. Genes Immun. 24:52. PubMed
  297. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  298. Sun Y, et al. 2023. Cell Mol Life Sci. 80:63. PubMed
  299. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  300. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  301. Zander R, et al. 2022. Immunity. 55:475. PubMed
  302. Qiu Z, et al. 2022. J Exp Med. 219:. PubMed
  303. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  304. Hamdi L, et al. 2022. Ann Clin Transl Neurol. 9:1792. PubMed
  305. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  306. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  307. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  308. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  309. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  310. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  311. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  312. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  313. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  314. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  315. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  316. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  317. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  318. Peymanfar Y, et al. 2023. Int J Mol Sci. 24:. PubMed
  319. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  320. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
  321. Iwanami N, et al. 2023. Nat Commun. 14:3645. PubMed
  322. Solvay M, et al. 2023. J Immunother Cancer. 11:. PubMed
  323. Wang Z, et al. 2023. Sci Adv. 9:eabo4100. PubMed
  324. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  325. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  326. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  327. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  328. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  329. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  330. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  331. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  332. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  333. He R, et al. 2021. J Immunol. 206:2353. PubMed
  334. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  335. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  337. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  338. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  339. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  340. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  341. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  342. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  343. Toomer G, et al. 2022. Viruses. 14:. PubMed
  344. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  345. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  346. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  347. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  348. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  349. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  350. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  351. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  352. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  353. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  354. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  355. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  356. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  357. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  358. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  359. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  360. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  361. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  362. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  363. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  364. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  365. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  366. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  367. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  368. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  369. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  370. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  371. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  372. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  373. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  374. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  375. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  376. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  377. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  378. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  379. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  380. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  381. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  382. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  383. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  384. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  385. White C, et al. 2014. J Immunol. 193:5933. PubMed
  386. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  387. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  388. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  389. Feng H, et al. 2020. J Dermatol. 47:147. PubMed
  390. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  391. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  392. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  393. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  394. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  395. He X, et al. 2021. Small. 17:e2007165. PubMed
  396. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  397. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  398. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  399. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  400. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  401. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  402. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  403. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  404. Wang Z, et al. 2022. Nat Biomed Eng. 6:791. PubMed
  405. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  406. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  407. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  408. Deng Z, et al. 2020. World J Gastrointest Oncol. 1091:12. PubMed
  409. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  410. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  411. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  412. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  413. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  414. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  415. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  416. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  417. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  418. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  419. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  420. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  421. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  422. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  423. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  424. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  425. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  426. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  427. Gebre MS, et al. 2022. NPJ Vaccines. 7:88. PubMed
  428. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  429. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  430. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  431. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  432. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  433. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  434. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  435. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  436. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  437. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  438. Lang V, et al. 2021. Elife. 10:. PubMed
  439. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  440. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  441. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  442. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  443. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  444. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  445. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  446. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  447. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  448. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  449. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  450. Ma K, et al. 2022. iScience. 25:104347. PubMed
  451. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  452. Gao X, et al. 2022. Front Immunol. 13:799331. PubMed
  453. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  454. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  455. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  456. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  457. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  458. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  459. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  460. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  461. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  462. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  463. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  464. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  465. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  466. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  467. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  468. Li J, et al. 2020. Development. :. PubMed
  469. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  470. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  471. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  472. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  473. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  474. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  475. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  476. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  477. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  478. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  479. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  480. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  481. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  482. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  483. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  484. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  485. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  486. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  487. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  488. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  489. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  490. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  491. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  492. Pan L, et al. 2022. Front Immunol. 13:837497. PubMed
  493. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  494. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  495. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  496. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  497. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  498. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  499. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  500. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  501. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  502. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  503. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  504. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  505. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  506. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  507. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  508. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  509. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  510. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  511. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  512. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  513. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  514. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  515. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  516. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  517. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  518. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  519. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  520. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  521. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  522. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  523. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  524. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  525. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  526. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  527. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  528. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  529. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  530. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  531. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  532. Gawish R, et al. 2022. Elife. 11:. PubMed
  533. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  534. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  535. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  536. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  537. Zeng A, et al. 2020. Oncol Rep. . PubMed
  538. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  539. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  540. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  541. Lestari SR, et al. 2020. J Ayurveda Integr Med. 11:414. PubMed
  542. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  543. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  544. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  545. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  546. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
RRID
AB_312690 (BioLegend Cat. No. 100405)
AB_312691 (BioLegend Cat. No. 100406)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account